Invitek Diagnostics Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 17

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Invitek Diagnostics General Information

Description

Developer of diagnostic products based in Berlin, Germany. The company develops diagnostic products, nucleic acid sample, manual & automated purification, mutation detection & sequencing services and proprietary core technologies for nucleic acid purification, enabling clients to avail quality diagnostic products and biotechnology research services.

Contact Information

Website
www.invitek.com
Formerly Known As
Invitek Gesellschaft für Biotechnik & Biodesign, Invitek Molecular
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Robert-Roessle-Str. 10
  • 13125 Berlin
  • Germany
+49 030
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Parent Company
ALS
Vertical(s)
Corporate Office
  • Robert-Roessle-Str. 10
  • 13125 Berlin
  • Germany
+49 030

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Invitek Diagnostics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Invitek Diagnostics‘s full profile, request access.

Request a free trial

Invitek Diagnostics Patents

Invitek Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-8735060-B2 Method for isolating high-purity rna by means of paramagnetic microparticles and nanoparticles Inactive 29-Jul-2009
US-9593325-B2 Stable lysis buffer mixture for extracting nucleic acids Active 22-Apr-2008
US-20140154776-A1 Stable lysis buffer mixture for extracting nucleic acids Active 22-Apr-2008
DE-10253351-B4 Novel buffer formulations for the isolation, purification and recovery of long- and short-chain nucleic acids Inactive 08-Nov-2002
DE-10253351-A1 Isolation of nucleic acid by binding to solid phase, useful e.g. in forensic or diagnostic medicine, uses binding buffer containing monovalent and multivalent ions, eliminates need for alcohol in wash buffer Active 08-Nov-2002 C12N15/1006
To view Invitek Diagnostics’s complete patent history, request access »

Invitek Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Invitek Diagnostics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Invitek Diagnostics‘s full profile, request access.

Request a free trial

Invitek Diagnostics FAQs

  • When was Invitek Diagnostics founded?

    Invitek Diagnostics was founded in 1992.

  • Where is Invitek Diagnostics headquartered?

    Invitek Diagnostics is headquartered in Berlin, Germany.

  • What is the size of Invitek Diagnostics?

    Invitek Diagnostics has 17 total employees.

  • What industry is Invitek Diagnostics in?

    Invitek Diagnostics’s primary industry is Biotechnology.

  • Is Invitek Diagnostics a private or public company?

    Invitek Diagnostics is a Private company.

  • What is Invitek Diagnostics’s current revenue?

    The current revenue for Invitek Diagnostics is .

  • Who are Invitek Diagnostics’s investors?

    The Stratech Group has invested in Invitek Diagnostics.

  • When was Invitek Diagnostics acquired?

    Invitek Diagnostics was acquired on 19-Jan-2023.

  • Who acquired Invitek Diagnostics?

    Invitek Diagnostics was acquired by ALS.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »